Resumo

Rationale: For decades, cannabis has been the most widely used illicit substance in the world, particularly among youth. Research suggests that mental health problems associated with cannabis use may result from its effect on reward brain circuit, emotional processes, and cognition. However, findings are mostly derived from correlational studies and inconsistent, particularly in adolescents. Objectives and Methods: Using data from the IMAGEN study, participants (non-users, persistent users, abstinent users) were classified according to their cannabis use at 19 and 22 years-old. All participants were cannabis-naïve at baseline (14 years-old). Psychopathological symptoms, cognitive performance, and brain activity while performing a Monetary Incentive Delay task were used as predictors of substance use and to analyze group differences over time. Results: Higher scores on conduct problems and lower on peer problems at 14 years-old (n = 318) predicted a greater likelihood of transitioning to cannabis use within 5 years. At 19 years of age, individuals who consistently engaged in low-frequency (i.e., light) cannabis use (n = 57) exhibited greater conduct problems and hyperactivity/inattention symptoms compared to non-users (n = 52) but did not differ in emotional symptoms, cognitive functioning, or brain activity during the MID task. At 22 years, those who used cannabis at both 19 and 22 years-old n = 17), but not individuals that had been abstinent for ≥ 1 month (n = 19), reported higher conduct problems than non-users (n = 17). Conclusions: Impairments in reward-related brain activity and cognitive functioning do not appear to precede or succeed cannabis use (i.e., weekly, or monthly use). Cannabis-naïve adolescents with conduct problems and more socially engaged with their peers may be at a greater risk for lighter yet persistent cannabis use in the future.

Idioma originalInglês
Páginas (de-até)1447-1461
Número de páginas15
RevistaPsychopharmacology
Volume241
Número de emissão7
DOIs
Estado da publicaçãoPublicadas - 26 mar. 2024

Nota bibliográfica

© 2024. The Author(s).

Financiamento

Financiadoras/-esNúmero do financiador
National Institutes of Health, Science Foundation Ireland
King's College London
Institut national de la santé et de la recherche médicale
National Institute for Health and Care Research
Fédération pour la Recherche sur le Cerveau
South London and Maudsley NHS Foundation Trust
Université Paris-Sud
European Union’s Horizon 2020 - Research and innovation program
Bundesministerium für Bildung und Forschung01GL1745B, 01GS08152, 01EV0711, AERIAL 01EE1406A, 01EE1406B
Deutsche ForschungsgemeinschaftNE 1383/14–1, SM 80/7–2, SFB 940, TRR 265
ERA-Net NEURONANR-18-NEUR00002-01—ADORe, AF12-NEUR0008-01—WM2NA
Fondation pour la Recherche MédicaleDPA20140629802
European Union’s Horizon 2020 - Research and innovation program695313
Medical Research Foundation and Medical Research CouncilMR/R00465X/1, MR/S020306/1
Fundação para a Ciência e Tecnologia2021.06791
Agence Nationale de la RechercheANR-12-SAMA-0004
European Union-funded FP6LSHM-CT- 2007–037286
European Research Council785907, 945539
Fondation de France00081242
European Commission101057429
National Institutes of HealthR01DA049238, 1R56AG058854-01, PR-ST-0416–10001, U54 EB020403
Fondation de l'Avenir pour la Recherche Médicale AppliquéeAP-RM-17–013
Testosterone and Mental HealthRO1 MH085772-01A1
National Natural Science Foundation of China82150710554
Medical Research CouncilMR/N000390/1
Não adicionado16/ERCD/3797
ANR-12-SAMA-0004AAPG2019—GeBra

Impressão digital

Mergulhe nos tópicos de investigação de “Light Cannabis Use and the Adolescent Brain: An 8-years Longitudinal Assessment of Mental Health, Cognition, and Reward Processing“. Em conjunto formam uma impressão digital única.

Citar isto